Show results for
Refine by
Liquid Biopsy Suppliers Serving Belarus
54 companies found
based inDaejeon, SOUTH KOREA
PANAGENE have been supplying Peptide Nucleic Acid (PNA) worldwide and exclusively since 2006 based on our unique invention of efficient synthesis of PNA with high purity, and nowadays we are possessing the best knowledge on PNA and the largest ...
NRAS mutation is found in several cancers such as melanoma (13~25%), colorectal cancer (1~6%), lung cancer (1%), thyroid cancer (7%) and hepatocellular carcinoma (10%). It is know that the drug response against colorectal cancer medicine such as ...
based inEdmonton, ALBERTA (CANADA)
Nanostics is a medical device and biotechnology company with a mission to provide clarity to people about their health by enabling better diagnosis and improving health care decisions through machine learning and extracellular vesicle detection. ...
Our core technology ClarityDX® can: Identify biomarkers expressed by diseased cells/tissues. Indicate if treatment is needed. Predict treatment response and resistance. Stratify disease stage. Identify disease ...
based inNew Taipei City, TAIWAN
Established 2011 in Taiwan's aspiring capital Taipei, Zinexts Life Science has become a leading Biotechnology Company that is designing, developing and manufacturing a wide array of reliable, user friendly and cost effective Molecular Biology ...
based inNew York, NEW YORK (USA)
miR Scientific, LLC is a healthcare company committed to transforming global cancer management by providing early and highly accurate detection, characterization, and monitoring of disease. The Company has developed the miR Disease Management ...
The initial test delivered by the miR Disease Management Platform® is the miR Sentinel™ Prostate Cancer Test, the first and only standalone, non-invasive liquid biopsy urine test that accurately detects, ...
based inManchester, UNITED KINGDOM
Yourgene Health is a leading international molecular diagnostics group with an integrated portfolio of technologies and services to enable genomic medicine. Our mission to enable scientific advances to positively impact human health remains at the ...
based inSint-Denijs Westrem, BELGIUM
We are a commercial stage medical device company developing the alfapump® platform for the treatment of fluid overload in liver disease, malignant ascites and heart failure where diuretics are no longer effective. The alfapump®, is a fully ...
Ascites is also a common complication of certain late-stage cancers due to fluid build-up in the peritoneal cavity from a number of causes including draining of the lymph system. While life expectancy for many cancer patients with malignant ascites ...
based inXiamen, CHINA
Amoy Diagnostics Co., Ltd. (AmoyDx) is an R&D based diagnostic company, focusing on molecular diagnostics for oncology precision medicine. With completely independent intellectual property rights of ADx-ARMS®, Super-ARMS®, ddCapture® and ADx-HANDLE® ...
based inLa Vista, NEBRASKA (USA)
Streck is an ISO-certified biotech company with proven proprietary science and an unwavering commitment to the highest standards in developing and manufacturing Quality Control and diagnostic products in hematology, immunology, molecular ...
Cell-Free DNA BCT is a direct-draw venous whole blood collection device intended for the collection, stabilization and transport of venous whole blood samples for use in conjunction with cell-free DNA next generation sequencing ...
based inHeidelberg, GERMANY
Hummingbird is harnessing the predictive power of blood-borne miRNAs to provide insights into human health and disease. Analysis of miRNAs with Hummingbird’s platform holds the potential for early disease detection, disease-specific prognostics, ...
MiRNAs are small, highly conserved, non-coding RNAs playing crucial roles in the regulation of virtually all aspects of living ...
based inSan Diego, CALIFORNIA (USA)
Nucleix is a liquid biopsy company revolutionizing cancer treatment with earlier disease detection, at a time when intervention can bring the greatest impact for patients. Leveraging PCR-based epigenetics, our pioneering testing approach uses ...
Liquid biopsies are a new powerful tool in cancer diagnostics that is transforming patient healthcare. Body fluids such as blood or urine are obtained from the patient and analyzed for the presence of circulating ...
based inAuburn, ALASKA (USA)
SiO2 Materials Science is focused on three core segments: Pharmaceuticals, Molecular Diagnostics, and Consumer Healthcare. In the pharma segment, we solve more than 30 problems including some of the most challenging related to drug stability, drug ...
based inSeoul, SOUTH KOREA
We Develop Next-Generation In Vitro Diagnostic System and Enabling Technologies For Liquid Biopsy. Curiosis’ expert team of scientists and engineers are dedicated to provide the best research and diagnostics solution with the core technologies of ...
based inNotting Hill, AUSTRALIA
INOVIQ Ltd (ASX:IIQ) (INOVIQ) is developing and commercialising an innovative portfolio of diagnostic and exosome-based solutions for the earlier detection, diagnosis, prognosis and monitoring of cancer and other diseases to improve patient outcomes ...
EXO-NET RUO - a pan-exosome capture tool for isolation of exosomes from body fluids including plasma, urine, and saliva. Exosomes are small membrane-enclosed vesicles actively secreted by most cells into biological fluids including serum, plasma, ...
based inDoylestown, PENNSYLVANIA (USA)
Incorporated in PA in 2011, our MISSION is to translate our circulating cell-free DNA (cfDNA) in urine technology into improved cancer screening and management by liquid biopsy towards our VISION of decreased global cancer mortality. Our proprietary ...
based inBerlin, GERMANY
We revolutionize the way of cancer diagnostics using our unique, proprietary DNA methylation biomarker technology. Epigenomics develops and commercializes patient-friendly, blood-based diagnostic tests across multiple cancer indications with high ...
Colorectal cancer is curable in about 90% of cases if detected early. Nevertheless, this disease is one of the most frequent causes of cancer-related deaths in the industrialized world. Regular screening can prevent colorectal cancer. Epi ...
based inPalo Alto, CALIFORNIA (USA)
Nirmidas Biotech was founded in September of 2013. We are a member of the Janssen Labs (JLABS) and QB3 programs, the Stanford StartX Med Program, and the MIT Industrial Liaison Program (MIT ILP). We are also a StartX Med COVID-19 Task Force Company ...
based inPuchheim, GERMANY
Originally founded in 1998 as an independent entity by Horst Lindhofer, we have assisted in the preclinical and clinical development of all Triomab® antibodies that are under development or received market approval, including that of Removab®, the ...
We combine leading scientific expertise in tumor immunology and virus-induced immune disorders with dedicated analytical know-how. Our services comprise Liquid Biopsy diagnostics with the analysis of virus-infected ...
based inMilan, ITALY
Tethis S.p.A is based in Milan, Italy, and is developing a novel workflow to bring liquid biopsy in the clinical practice for the precise management of cancer. Tethis’ technology points to standardization of the blood sample preparation to provide ...
A complete analytical evaluation of morphological, proteomic and genetic features is possible at single cell level or on cell-free content. All the traditional biopsies’ techniques, such as cytology, immunocytochemistry, ...
based inHallbergmoos, GERMANY
Xpedite Diagnostics is at the forefront of advancing molecular diagnostics to the point-of-care level, focusing on revolutionizing the nucleic acid extraction process. The company's groundbreaking SwiftX™ technology eliminates the reliance on ...
The SwiftX™ cfDNA Extraction Kit is designed for efficient extraction of cell-free DNA (cfDNA) from large volumes of serum, plasma, and urine samples in under 15 minutes. This kit is particularly beneficial for applications in oncology ...
based inNottingham, UNITED KINGDOM
Oncimmune is a leading immuno diagnostics developer, primarily focused on the growing fields of immuno-oncology, autoimmune disease and infectious diseases. Our growing range of diagnostic products can detect early-stage cancer and our service-based ...
Oncimmune’s proprietary biomarker discovery engine, which is leveraged in our ImmunoINSIGHTS services to discover and validate novel biomarkers that can help stratify patients in multiple cancer indications and with different autoimmune ...